APA (7th ed.) Citation

Yee, K. L., Sanchez, R. I., Auger, P., Liu, R., Fan, L., Triantafyllou, I., . . . Merck & Co., I. (2017). Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects. Antimicrobial Agents and Chemotherapy ; volume 61, issue 2 ; ISSN 0066-4804 1098-6596. https://doi.org/10.1128/aac.01757-16

Chicago Style (17th ed.) Citation

Yee, Ka Lai, et al. "Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects." Antimicrobial Agents and Chemotherapy ; Volume 61, Issue 2 ; ISSN 0066-4804 1098-6596 2017. https://doi.org/10.1128/aac.01757-16.

MLA (9th ed.) Citation

Yee, Ka Lai, et al. "Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects." Antimicrobial Agents and Chemotherapy ; Volume 61, Issue 2 ; ISSN 0066-4804 1098-6596, 2017, https://doi.org/10.1128/aac.01757-16.